DK3481811T3 - Industriel fremgangsmåde til forberedelse af cariprazin - Google Patents

Industriel fremgangsmåde til forberedelse af cariprazin Download PDF

Info

Publication number
DK3481811T3
DK3481811T3 DK17739701.5T DK17739701T DK3481811T3 DK 3481811 T3 DK3481811 T3 DK 3481811T3 DK 17739701 T DK17739701 T DK 17739701T DK 3481811 T3 DK3481811 T3 DK 3481811T3
Authority
DK
Denmark
Prior art keywords
cariprazine
preparation
industrial process
industrial
Prior art date
Application number
DK17739701.5T
Other languages
English (en)
Inventor
József Neu
Sándor Garadnay
Tamás Szabó
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Application granted granted Critical
Publication of DK3481811T3 publication Critical patent/DK3481811T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK17739701.5T 2016-07-08 2017-07-07 Industriel fremgangsmåde til forberedelse af cariprazin DK3481811T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HUP1600420 2016-07-08
HU1700197A HU231173B1 (hu) 2016-07-08 2017-05-09 Ipari eljárás cariprazine előállítására
PCT/IB2017/054094 WO2018007986A1 (en) 2016-07-08 2017-07-07 Industrial process for the preparation of cariprazine

Publications (1)

Publication Number Publication Date
DK3481811T3 true DK3481811T3 (da) 2022-09-05

Family

ID=89992438

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17739701.5T DK3481811T3 (da) 2016-07-08 2017-07-07 Industriel fremgangsmåde til forberedelse af cariprazin

Country Status (22)

Country Link
EP (2) EP3481811B1 (da)
JP (1) JP7065824B2 (da)
CN (1) CN109476617B (da)
AU (1) AU2017292177B2 (da)
BR (1) BR112018077305A2 (da)
CA (1) CA3030102A1 (da)
DK (1) DK3481811T3 (da)
EA (1) EA036312B1 (da)
ES (1) ES2924995T3 (da)
GE (1) GEP20217217B (da)
HR (1) HRP20221037T1 (da)
HU (2) HU231173B1 (da)
IL (1) IL264074B (da)
LT (1) LT3481811T (da)
MX (2) MX2019000330A (da)
PL (1) PL3481811T3 (da)
PT (1) PT3481811T (da)
RS (1) RS63480B1 (da)
SG (1) SG11201811291QA (da)
SI (1) SI3481811T1 (da)
UA (1) UA123797C2 (da)
WO (1) WO2018007986A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110240548A (zh) * 2018-03-09 2019-09-17 上虞京新药业有限公司 一种卡利拉嗪中间体的制备方法
CN110317182B (zh) * 2018-03-29 2021-10-15 上虞京新药业有限公司 一种卡利拉嗪的制备方法
CN108586389B (zh) * 2018-06-29 2020-06-12 成都福柯斯医药技术有限公司 一种合成卡利拉嗪的方法
CN111712486A (zh) * 2018-09-21 2020-09-25 上海诚妙医药科技有限公司 卡利拉嗪盐酸盐的新晶型及其制备方法及其用途
CN114539185A (zh) * 2020-11-24 2022-05-27 上海博志研新药物技术有限公司 一种卡利拉嗪及其中间体的制备方法
HUP2100108A1 (hu) 2021-03-12 2022-09-28 Richter Gedeon Nyrt Eljárás és berendezés gyógyászatilag alkalmazható piperazin származékok folyamatos áramú, áramlásos konszekutív redukálással történõ elõállítására
CN115806510B (zh) * 2023-02-03 2023-04-21 成都福柯斯医药技术有限公司 3-反式-4-(2-羟乙基)环己基-1,1-二甲基脲的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010009912A1 (en) 1995-02-10 2001-07-26 Christos Tsaklakidis New derivatives of pyridil piperazine or pyridazinyl piperazyl, process for production thereof and medicaments containing these compounds
HU227543B1 (en) * 2001-09-28 2011-08-29 Richter Gedeon Nyrt N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
UY29161A1 (es) 2004-10-15 2006-04-28 Bayer Pharmaceuticals Corp Nuevos heterociclos
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HU229858B1 (en) 2008-12-17 2014-10-28 Richter Gedeon Nyrt Process for the preparation of trans 4-amino-cyclohexyl acetic acid ethyl ester hcl
WO2014031162A1 (en) * 2012-08-20 2014-02-27 Forest Laboratories Holdings Limited Crystalline form of carbamoyl-cyclohexane derivatives
HU231227B1 (hu) * 2012-11-29 2022-03-28 Richter Gedeon Nyrt. Transz-4-{2-[4-(2,3-diklórfenil)-piperazin-1-il]-etil}N,N-dimetilkarbamoil-ciklohexilamin skizofrénia negatív tüneteinek kezelésére
ITMI20131693A1 (it) 2013-10-14 2015-04-15 Chemo Res S L Derivati della 1,4-cicloesilammina e loro preparazione
CN105218484B (zh) * 2015-09-14 2018-02-23 安徽省逸欣铭医药科技有限公司 酒石酸卡利拉嗪及其制备方法和医药用途
CN105330616B (zh) 2015-12-09 2017-09-26 苏州明锐医药科技有限公司 卡利拉嗪的制备方法

Also Published As

Publication number Publication date
EP3481811A1 (en) 2019-05-15
JP7065824B2 (ja) 2022-05-12
AU2017292177B2 (en) 2021-07-29
SI3481811T1 (sl) 2022-10-28
RS63480B1 (sr) 2022-08-31
AU2017292177A1 (en) 2019-02-07
CN109476617A (zh) 2019-03-15
CN109476617B (zh) 2023-04-04
PL3481811T3 (pl) 2022-09-12
WO2018007986A1 (en) 2018-01-11
JP2019527210A (ja) 2019-09-26
SG11201811291QA (en) 2019-01-30
UA123797C2 (uk) 2021-06-02
EP3481811B1 (en) 2022-05-25
PT3481811T (pt) 2022-08-23
EA201990097A1 (ru) 2019-06-28
HUP1700197A2 (en) 2018-09-28
ES2924995T3 (es) 2022-10-13
CA3030102A1 (en) 2018-01-11
HUE059285T2 (hu) 2022-11-28
GEP20217217B (en) 2021-02-10
EA036312B1 (ru) 2020-10-26
BR112018077305A2 (pt) 2019-04-02
HRP20221037T1 (hr) 2022-11-11
MX2019000330A (es) 2019-05-20
IL264074A (en) 2019-01-31
EP4043446A3 (en) 2023-01-18
EP4043446A2 (en) 2022-08-17
LT3481811T (lt) 2022-08-25
MX2021012390A (es) 2022-07-18
IL264074B (en) 2021-10-31
HU231173B1 (hu) 2021-06-28

Similar Documents

Publication Publication Date Title
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3376859T3 (da) Mikroorganismer til fremstilling af insektferomoner og relaterede forbindelser
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3377201T3 (da) Fremgangsmåde til fremstilling af membraner
DK3563156T3 (da) Fremgangsmåde til separering af biomolekyler
DK3464306T3 (da) Fremgangsmåder til fremstilling af phosphorodiamidat-morpholino-oligomerer
DK3481811T3 (da) Industriel fremgangsmåde til forberedelse af cariprazin
DK3166904T3 (da) Fremgangsmåde til fremstilling af betonelementer
DK3515990T3 (da) Fremgangsmåde til fremstilling af lignocellulosematerialer
DK3312270T3 (da) Fremgangsmåde til fremstilling af plader med høj ydeevne
DK3359522T3 (da) Proces til fremstilling af N-Boc-bifenylalaninol
DK3436074T3 (da) Thiazolidforbindelser til behandling af virale infektioner
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3218396T3 (da) Fremgangsmåde til fremstilling af højaffinitets antistoffer
DK3261661T3 (da) Menotropin til behandling af infertilitet
DK3490938T3 (da) Fremgangsmåder til dannelse af titancatecholkomplekser
DK3262023T3 (da) Fremgangsmåde til fremstillingen af diener
DK3408015T3 (da) Fremgangsmåde til fremstilling af emulsioner
DK3524063T3 (da) Fremgangsmåde til fremstilling af nukleinsyrekrydderi
DK3274143T3 (da) Fremgangsmåde til fremstilling af lignocellulosematerialer
DK3250523T3 (da) Fremgangsmåde til fremstillingen af en silikasmeltemasse
DK3166923T3 (da) Fremgangsmåde til fremstilling af substituerede phenylalkaner
DK3416936T3 (da) Fremgangsmåde til fremstilling af methanol
DK3495339T3 (da) Fremgangsmåde til fremstilling af reaktionsprodukt